Data in Biotech

How to Identify the Blind Spots in Your Biotech's Genomic Data Before They Cost You a Drug Target

Most drug discovery genomic data comes from a thin slice of the world, and that bias follows every decision downstream. Your team can run a Mendelian randomization study

How to Turn Single-Cell Data Into a New Class of Cell-Depleting Therapies

Why treating the cell, not the protein, could turn chronic disease treatment into something closer to a cure. You've built single-cell pipelines that spit out clusters,

Why Biotech Talks About AI But Won't Pay for the Data It Needs

Everyone in biotech agrees AI needs more data. Almost no one is willing to pay for it. If you're trying to build or buy a biotech AI model, you've hit the same wall: pre

Beyond Language: Why Drug Discovery Needs Physical AI, Not Just Large Language Models

In this episode of Data in Biotech, host Ross Katz sits down with Woody Sherman, Founder and Chief Innovation Officer at PsiThera, for a conversation on why AI can transf

Synthesizable by Design: Rethinking AI's Role in Small Molecule Drug Discovery

In this episode of Data in Biotech, host Ross Katz sits down with Paul Finn, Chief Scientific Officer at Oxford Drug Design, for a conversation on what it actually takes

From Tissue to Mechanism to Decision: Building AI for Computational Oncology

In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a

Cavities in the Data: Building FDA-Cleared AI for Dental Imaging with Overjet

In this episode of Data in Biotech, host Ross Katz sits down with Sadegh Salehi, Director of Research and Principal Scientist at Overjet, to explore what rigorous model e

Data as a Moat: Why Biotech's Most Valuable Asset is Buried in a Hard Drive

In this episode of Data in Biotech, host Ross Katz sits down with Jesse Johnson, founder of Merelogic, a software consulting firm specializing in data infrastructure for

The Patient is Not a Document: Foundation Models for Biomedical AI with Standard BioModel

In this episode of Data in Biotech, host Ross Katz sits down with Kevin Brown, co-founder of Standard BioModel, to explore one of the most ambitious projects in biomedica

Physics, Free Energy, & Drug Discovery: Inside Schrödinger's Computational Platform

In this episode of Data in Biotech, Ross Katz sits down with Robert Abel, Chief Scientific Officer of the Platform at Schrödinger, to explore how physics-based computatio

AI in biotech: separating hype from reality with Ben Locwin

In this episode of Data in Biotech, host Ross Katz sits down with Ben Locwin, Vice President at Reliant Life Sciences, to explore the evolving landscape of artificial int

3D Printing Therapeutics at Scale with Aprecia Pharmaceuticals

In this episode of Data in Biotech, Ross Katz sits down with Kyle Smith and Jacob Mayer from Aprecia Pharmaceuticals to explore how 3D printing is transforming pharmaceut

Success-Driven Drug Discovery with OpenBench CEO James Yoder

In this episode of Data in Biotech, host Ross Katz sits down with James Yoder, Founder and CEO of OpenBench, to unpack a radical new approach to early-stage drug discover

Brant Peterson on Valo Health’s patient-first approach to drug discovery

Brant Peterson, Vice President & Fellow at Valo Health, joins Data in Biotech to explore how his team leverages real-world data, genetic insights, and machine learning to

Inside Dash Bio’s productized CRO model with Ander Tallet

Ander Tallet, co-founder and COO of Dash Bio and CEO of DigitalRadius, joins Ross Katz to discuss transforming the traditional CRO model through automation, transparency,

From discovery to delivery: AI’s impact on nanomedicine

In this episode of Data in Biotech, Ross Katz chats with Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, about how AI and machine learning are revolutionizin

Jaidev Chakka on building the future of bioprinted medicine

In this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting

From screening to IND: How Veloxity accelerates critical drug decisions

In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and

Revolutionizing bioanalysis with high-resolution mass spec

In this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma

Mastering solubility and stability in drug development with Serán BioScience

In this episode of Data in Biotech, Ross Katz chats with Wesley Tatum, Principal Engineer at Serán BioScience, about the intricacies of formulating low-solubility drug pr